Maxisulin, created in 1996 (Germany), from 223 sister brands and 17478 competing brands. The Maxisulin brand is owned by Daiichi Sankyo, a company listed in Francfort. Its International Securities Identification Number (ISIN) is JP3475350009. Maxisulin belongs to the Drug Manufacturers business sector.

Maxisulin is a brand of Daiichi Sankyo (D4S) Sustainability

International deposit : 1996 Business sector Drug Manufacturers
Here is the evolution of interest in Daiichi Sankyo "sustainability" criteria around the world over the past five years. The graph shows the evolution of the search rate over time, where the value 100 indicates the week with the most searches.
What is the brand's web response on its sustainability
Result of Google's query: "Maxisulin sustainability"
Sustainability -> Share price